» Articles » PMID: 20299028

Pulmonary Vein Isolation and Autonomic Denervation for the Management of Paroxysmal Atrial Fibrillation by a Minimally Invasive Surgical Approach

Overview
Date 2010 Mar 20
PMID 20299028
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in technology such as epicardial bipolar radiofrequency pulmonary vein isolation, ganglionated plexi identification, and isolation and thoracoscopic left atrial appendage exclusion have enabled less invasive surgical options for management of atrial fibrillation.

Methods: We performed a prospective, nonrandomized study of consecutive patients with symptomatic paroxysmal atrial fibrillation undergoing a video-assisted, minimally invasive surgical ablation procedure. The procedure consisted of bilateral, epicardial pulmonary vein isolation with bipolar radiofrequency, partial autonomic denervation, and selective excision of the left atrial appendage. Minimum follow-up was 1 year with long-term monitoring (24-hour continuous, 14-day event or pacemaker interrogation).

Results: Between March 2005 and January 2008, 52 patients (35 male), mean age 60.3 years (range, 42-79 years) underwent the procedure. The left atrial appendage was isolated in 88.0% (44/50). Average hospital stay was 5.2 days (range 3-10 days). There were no operative deaths or major adverse cardiac events. On long-term monitoring, freedom from atrial fibrillation/flutter/tachycardia was 86.3% (44/51) and 80.8% (42/52) at 6 and 12 months, respectively. Antiarrhythmic drugs were stopped in 33 of 37 patients and warfarin in 30 of 37 of the patients in whom ablation was successful at 12 months. Freedom from symptoms attributed to atrial fibrillation/flutter/tachycardia was 78.0% (39/50) at 6 months and 63.8% (30/47) at 12 months.

Conclusions: Minimally invasive surgical ablation is effective in the management of paroxysmal atrial fibrillation as evidenced by freedom from atrial arrythmias by long-term monitoring at 12 months. Measuring success using clinical symptoms underestimated clinical success as compared with long-term monitoring.

Citing Articles

Narrative Review: Surgical and Hybrid Management of Atrial Fibrillation.

Trohman R Cardiol Ther. 2024; 13(3):493-528.

PMID: 39134905 PMC: 11333670. DOI: 10.1007/s40119-024-00377-2.


Intrinsic Cardiac Neuromodulation in the Management of Atrial Fibrillation- A Potential Missing Link?.

Aksu T, Gupta D, Skeete J, Huang H Life (Basel). 2023; 13(2).

PMID: 36836740 PMC: 9966489. DOI: 10.3390/life13020383.


Minimally-invasive cardiac surgery: a bibliometric analysis of impact and force to identify key and facilitating advanced training.

Karsan R, Allen R, Powell A, Beattie G J Cardiothorac Surg. 2022; 17(1):236.

PMID: 36114506 PMC: 9479391. DOI: 10.1186/s13019-022-01988-3.


Safety and long-term efficacy of thoracoscopic Epicardial ablation in patients with paroxysmal atrial fibrillation: a retrospective study.

Johnkoski J, Miles B, Sudbury A, Osman M, Munir M, Balla S J Cardiothorac Surg. 2019; 14(1):188.

PMID: 31694695 PMC: 6836534. DOI: 10.1186/s13019-019-1018-4.


Neuromodulation for Ventricular Tachycardia and Atrial Fibrillation: A Clinical Scenario-Based Review.

Zhu C, Hanna P, Rajendran P, Shivkumar K JACC Clin Electrophysiol. 2019; 5(8):881-896.

PMID: 31439288 PMC: 6773263. DOI: 10.1016/j.jacep.2019.06.009.